Details for New Drug Application (NDA): 016211
✉ Email this page to a colleague
NDA 016211 describes MIOCHOL, which is a drug marketed by Novartis and Bausch And Lomb and is included in two NDAs. Additional details are available on the MIOCHOL profile page.
The generic ingredient in MIOCHOL is acetylcholine chloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetylcholine chloride profile page.
The generic ingredient in MIOCHOL is acetylcholine chloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetylcholine chloride profile page.
Summary for 016211
| Tradename: | MIOCHOL |
| Applicant: | Novartis |
| Ingredient: | acetylcholine chloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016211
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SOLUTION;OPHTHALMIC | Strength | 20MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
